Sarcoma trials in China

In China 106 Also abroad 605

106 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
Where
Dongguan, Guangzhou, Shanghai
Age
1 year to 50 years
People
10
Run by
Sun Yat-Sen University Cancer Center
See details and how to joinNCT06836505
Phase 3Taking people
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Where
Guangzhou
Age
0 years to 18 years
People
300
Run by
Yizhuo Zhang
See details and how to joinNCT06836492
Phase 2Taking people
Evaluation of the Efficacy and Safety of Pazopanib in Combination with TGI/CIV for Recurrent or Refractory Rhabdomyosarcoma in Children or Adolescents
Where
Jinan
Age
2 years to 18 years
People
38
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06816771
Phase 1/2Taking people
B7-H3 NIR Imaging for Osteosarcoma Surgery
Where
Beijing
Age
18 years to 60 years
People
32
Run by
Peking University People's Hospital
See details and how to joinNCT06778603
No phaseTaking people
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
Where
Hangzhou
Age
18 years to 80 years
People
20
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06760221
Phase 2Taking people
Clinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Where
Beijing
Age
18 years to 75 years
People
40
Run by
CNBG-Virogin Biotech (Shanghai) Ltd.
See details and how to joinNCT06126510
Phase 2Taking people
Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors
Where
Shanghai
Age
18 years and over
People
100
Run by
Fudan University
See details and how to joinNCT06684327
No phaseTaking people
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Where
Shanghai
Age
6 years to 80 years
People
40
Run by
Ruijin Hospital
See details and how to joinNCT06644287
Phase 2Taking people
Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma
Where
Beijing
Age
14 years to 70 years
People
50
Run by
Peking University People's Hospital
See details and how to joinNCT06714383
Phase 2Taking people
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
Where
Shanghai
Age
14 years to 40 years
People
22
Run by
Fudan University
See details and how to joinNCT06699472
Phase 2Not yet taking people in China
First-line Treatment of Advanced/unresectable DDLPS
Where
Shanghai
Age
18 years to 75 years
People
49
Run by
Fudan University
See details and how to joinNCT06694324
Phase 2Taking people
ARTEMIS-002: HS-20093 in Patients With Relapsed or Refractory Osteosarcoma and Other Sarcomas
Where
Beijing, Changsha, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin, Zhengzhou
Age
18 years and over
People
170
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT05830123
Phase 2Taking people
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Where
Beijing
Age
12 years to 18 years
People
30
Run by
Beijing Konruns Pharmaceutical Co., Ltd.
See details and how to joinNCT06564272
No phaseNot yet taking people in China
Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors
Where
Guangzhou
Age
18 years to 65 years
People
98
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06550765
Phase 4Taking people
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Where
Guangzhou
Age
18 years to 75 years
People
39
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06506838
Phase 2Taking people
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
Where
Guangzhou
Age
2 years to 21 years
People
110
Run by
Yizhuo Zhang
See details and how to joinNCT06514313
No phaseTaking people
Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement
Where
Shanghai
Age
18 years to 55 years
People
50
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06111612
Phase 2Not yet taking people in China
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
Where
Beijing, Changchun, Changsha, Hangzhou, Jinan, Shanghai, Taiyuan, Tianjin, Ürümqi, Zhengzhou
Age
18 years to 75 years
People
54
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06500091
Phase 1/2Taking people
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 70 years
People
100
Run by
Second Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT05187338
Phase 1/2Taking people
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Where
Guangzhou
Age
1 year to 18 years
People
82
Run by
Sun Yat-sen University
See details and how to joinNCT06456892
Phase 1Taking people
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Where
Beijin, Beijing, Jina
Age
8 years to 40 years
People
44
Run by
Peking University People's Hospital
See details and how to joinNCT06340204
Phase 4Taking people
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Where
Wuhan
Age
18 years to 70 years
People
276
Run by
Tongji Hospital
See details and how to joinNCT06236022
Phase 2Taking people
Pulmonary Resectable Osteosarcoma Treated by Metastasectomy and Pre-operative Immunotherapy and Stereotactic Body Radiotherapy (PROMIS): a Prospective Clinical Trial
Where
Shanghai
Age
10 years to 65 years
People
43
Run by
Ruijin Hospital
See details and how to joinNCT06114225
Phase 2Taking people
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
Where
Shanghai
Age
10 years to 70 years
People
86
Run by
Ruijin Hospital
See details and how to joinNCT06074692
No phaseTaking people
Geno-radiomics Based Model for Evaluation of Immunotherapy and Targeted Therapy for Advanced Soft Tissue Sarcoma
Where
Beijing
Age
18 years to 75 years
People
60
Run by
Peking Union Medical College Hospital
See details and how to joinNCT06062927